84 related articles for article (PubMed ID: 16756013)
1. [Expression of lymphocyte activation markers in patients with gastrointestinal tumors at different stages].
Oleĭnik EK; Shibaev MI; Oleĭnik VM
Vopr Onkol; 2005; 51(5):571-4. PubMed ID: 16756013
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of circadian fluctuations in serum concentration of cortisol and TNF-alpha soluble receptors in gastrointestinal cancer patients.
Zubelewicz-Szkodzinska B; Muc-Wierzgon M; Wierzgon J; Brodziak A
Oncol Rep; 2001; 8(1):207-12. PubMed ID: 11115600
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study of the expression of activation markers on T-lymphocyte subpopulations in different forms of bronchial asthma].
Beda MV; Pavliuk AS; Veselova AV; Dement'eva EG; Solov'ev SS; Bart BIa; Koval'chuk LV
Ter Arkh; 1995; 67(3):26-9. PubMed ID: 7770797
[TBL] [Abstract][Full Text] [Related]
6. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.
Shibata M; Takekawa M; Amano S
Surg Today; 1998; 28(9):884-8. PubMed ID: 9744395
[TBL] [Abstract][Full Text] [Related]
7. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
8. [The activation processes of T-lymphocytes and their regulatory subpopulations in patients with pulmonary tuberculosis].
Mishin VIu; Pavliuk AS; Koval'chuk LV
Probl Tuberk; 1996; (1):38-40. PubMed ID: 8907485
[TBL] [Abstract][Full Text] [Related]
9. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
[TBL] [Abstract][Full Text] [Related]
10. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
Chadburn A; Inghirami G; Knowles DM
Hematol Pathol; 1992; 6(4):193-202. PubMed ID: 1362727
[TBL] [Abstract][Full Text] [Related]
11. [Selected markers of T cell activation in children with idiopathic uveitis].
Bakunowicz-Łazarczyk A; Moniuszko T; Sredzińska-Kita D; Mrugacz M
Klin Oczna; 2001; 103(4-6):191-3. PubMed ID: 11975016
[TBL] [Abstract][Full Text] [Related]
12. The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
Huang A; Quinn H; Glover C; Henderson DC; Allen-Mersh TG
Cancer Immunol Immunother; 2002 Mar; 51(1):53-7. PubMed ID: 11845260
[TBL] [Abstract][Full Text] [Related]
13. Expression of surface lymphocyte markers in various courses of gastrointestinal tumors.
Oleinik EK; Shibaev MI; Oleinik VM
Bull Exp Biol Med; 2004 Apr; 137(4):385-8. PubMed ID: 15452610
[TBL] [Abstract][Full Text] [Related]
14. Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer.
Lissoni P; Brivio F; Ferrante R; Vigore L; Vaghi M; Fumagalli E; Bucovec R; Malugani F; Fumagalli L
Int J Biol Markers; 2000; 15(1):22-5. PubMed ID: 10763136
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
[TBL] [Abstract][Full Text] [Related]
16. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
17. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy.
Huang YM; Pirskanen R; Giscombe R; Link H; Lefvert AK
Scand J Immunol; 2004 Apr; 59(4):408-14. PubMed ID: 15049785
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients.
Noh YH; Im G; Ku JH; Lee YS; Ahn MJ
J Korean Med Sci; 1999 Dec; 14(6):623-8. PubMed ID: 10642939
[TBL] [Abstract][Full Text] [Related]
19. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
Birkenfeld S; Noiman G; Krispin M; Schwartz S; Zakut H
Eur J Surg Oncol; 1989 Apr; 15(2):103-8. PubMed ID: 2703054
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer.
Huang P; Wang J; Guo Y; Xie W
J Cancer Res Clin Oncol; 2003 Mar; 129(3):192-8. PubMed ID: 12684893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
